Respected Sir/Madam,
My questions are as follows:
Peter Shalit, M.D.
Internal Medicine
1. Ideally, HAART should not injure or damage any organs. The most common serious toxicity of HAART is liver injury. This can be caused by protease inhibitors, NNRTI's, or NRTI's. This tends to be an early toxicity rather than a cumulative toxicity. Hence monitoring of liver function is important in the weeks after initiating HAART. Other organs, such as the kidneys, skin, and bone marrow, can sometimes be injured by certain components of HAART, but this is less common. Fat loss and/or accumulation sometimes accompanies HAART, and may be symptom of mitochondrial toxicity caused by certain nucleosides (the dideoxynucleosides - DDI, DDC, and D4T). Protease inhibitors may also be associated with changes in body fat distribution.
2. HAART does not usually cause malabsorption of nutrients. Sometimes HAART can cause diarrhea, but even then I am not aware that this produces a nutritional deficiency except perhaps in extreme cases.
3. There are no specific nutrients that should be increased in AIDS. However, in AIDS wasting syndrome, protein/calorie malnutrition can occur. People affected by this syndrome do best to consume calorie-dense foods (high in protein and fat content). A recent study also suggested that a multivitamin supplement can delay progression to AIDS in women who are not receiving HAART.
4/5. AIDS by itself does not increase ESR significantly, in my experience. A high ESR in the setting of AIDS usually is a reflection of a secondary opportunistic problem. HAART does not influence ESR.
6. HAART is the only treatment that predictably increases CD4 count. Other therapies, such as nutritional therapy or lifestyle modification, does not predictably increase CD4 count.
7. Gall bladder surgery is certainly possible in AIDS and is frequently performed. In my experience there is an increased incidence of postoperative fever and wound infection, but this has not been a barrier to performing this surgery.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, Roche and Trimeris, the National Library of Medicine, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.